Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression Free Survival for Patients with Chronic Myelomonocytic Leukemia

The treatment of patients with chronic myelomonocytic leukemia (CMML) with transplant has not been optimized. We retrospectively reviewed the data for 83 consecutive patients with CMML (47 with CMML-1/2 and 36 with CMML progressed to acute myeloid leukemia) who received an allogeneic stem cell trans...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Kongtim, Piyanuch, Popat, Uday, Jimenez, Antonio, Gaballa, Sameh, Fakih, Riad El, Rondon, Gabriela, Chen, Julianne, Bueso-Ramos, Carlos, Borthakur, Gautam, Pemmaraju, Naveen, Garcia-Manero, Guillermo, Kantarjian, Hagop, Alousi, Amin, Hosing, Chitra, Anderlini, Paolo, Khouri, Issa F., Kebriaei, Partow, Andersson, Borje S., Oran, Betul, Rezvani, Katayoun, Marin, David, Shpall, Elizabeth J., Champlin, Richard E., Ciurea, Stefan O.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4892364/
https://ncbi.nlm.nih.gov/pubmed/26343946
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2015.08.031
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados